NeutriSci International Inc. (NRXCF)
NeutriSci International Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Vancouver, BC, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $653,980. On trailing twelve-month figures it carries a trailing P/E of -0.40, a net margin of -168.4%. Its beta of -0.83 implies it has historically moved less than the broad market.
NeutriSci International Inc. is a company that operates globally, focusing on the creation, promotion, and supply of nutraceutical products across Canada, the United States, Europe, Asia, and South America. Among its notable offerings is "neuenergy," an energy-boosting tablet specifically designed to enhance concentration and mental sharpness. The company makes its products accessible to consumers through an extensive distribution network that includes both traditional brick-and-mortar retail stores and various online sales channels. Furthermore, NeutriSci International Inc. maintains strategic collaborations with partners such as LaSanta Botanicals, Nutritional High, and Naturally Splendid. The firm was established in 2009, and its corporate headquarters are located in Vancouver, Canada.
NeutriSci International Inc. is most often compared with the following Healthcare names: